Utah has become the first U.S. state to authorize an AI system to renew psychiatric drug prescriptions without requiring a doctor's sign-off. The state's Office of Artificial Intelligence Policy approved a one-year pilot with Legion Health, a Y Combinator-backed San Francisco startup, to begin the program in April 2026.

Under the pilot, Legion Health's $19-a-month AI chatbot can renew 15 lower-risk maintenance medications — including fluoxetine (Prozac), sertraline (Zoloft), and bupropion (Wellbutrin) — that a licensed clinician has already prescribed. The scope is deliberately narrow: patients must be considered stable, with no dose changes or psychiatric hospitalizations in the past year. The chatbot cannot issue new prescriptions, and controlled substances, benzodiazepines, antipsychotics, and lithium are all excluded.

To qualify, patients opt in, verify their identity, and document their existing prescription. The system screens for red flags — suicidal thoughts, severe side effects, pregnancy — and escalates those cases to a human clinician. After every 10 refills or six months, a check-in with a healthcare provider is required.

State officials framed the move as a response to the 500,000 Utah residents who lack access to mental health care. Psychiatrists are skeptical. University of Utah professor Brent Kious told The Verge that the tool may contribute to "an epidemic of over-treatment," and Harvard's John Torous questioned whether any current AI can safely navigate the nuanced, individual context that good prescribing requires.

Legion's CEO described the pilot as "the beginning of something much bigger than refills." Whether regulators in other states agree will determine how far that reaches.